As of January 27, 2025, Elutia (ELUT) has a market cap of $0.11 billion USD. According to our data, Elutia is ranked No.7636 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 27, 2025 | $0.11 B |
-4.38%
|
Dec 31, 2024 | $0.11 B |
73.15%
|
Dec 29, 2023 | $65.34 M |
-49.18%
|
Dec 30, 2022 | $0.13 B |
-32.54%
|
Dec 31, 2021 | $0.19 B |
-53.78%
|
Dec 31, 2020 | $0.41 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$148.05 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.99 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$21.30 B |
0.001 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.26 B |
1.229 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$113.21 B |
0.004 M
|
USA
|
Moderna
MRNA
|
$15.94 B |
0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.76 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$35.95 B |
0.001 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.12 B |
0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.49 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.98 B |
0.000 M
|
USA
|
Illumina
ILMN
|
$21.60 B |
-0.001 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.71 B |
0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
Market Cap | = | ELUT Stock Price | * | ELUT Shares Outstanding |
= | $3.13 | * | 30.25 M | |
= | $0.11 B |